BRANDS Meet Exomie and Lipologics, built on our platforms →
HoynozaTechnologies

Four platforms, one pipeline.

They were built to hand work to each other: one laboratory, one quality framework, and data that carries from stage to stage.

Researcher analysing results on a laptop beside a microscope
Shared analytics
Hand-offs

How the platforms connect.

Cells from one platform feed the next, and because they share a laboratory, a result at one stage is directly usable at the next.

How the platforms hand work to each other
STEMZACellsconditioned mediaHNEVVesiclespurified vesiclesHNOVAFormulationssamples to testHTAnswersOne laboratory, one quality framework. Select a platform to open it.
Shared foundations

What all four platforms share.

One laboratory

Work moves between platforms without leaving the building.

One quality framework

The same documentation and review applies to every lot.

Common data standards

Results are recorded in a form the next stage can use.

People who move across

Scientists work on more than one platform, so knowledge carries over.

Choosing

Choose by what you start with.

You start withBegin with
Cells you need to grow, characterise or validateSTEMZA
Vesicles, or a source you want to make them fromHNEV
A payload that needs protecting and deliveringHNOVA
A sample you need to testHT
Questions

About the platforms.

Can one programme use more than one platform?

Yes. Many do, and the shared laboratory is designed for that.

Are the platforms offered separately?

Yes. Each can be engaged on its own.

Is any of the output clinical grade?

No. Materials are research grade today, and GMP manufacturing is a planned build-out.

How do the platforms relate to the brands?

HNEV underlies Exomie and HNOVA underlies Lipologics.

Not sure where to start?

Describe the problem and we will tell you which platform fits.

Contact us →
↑Start a project